critics News
Most Popular critics Story
PDUFA debate highlights drug safety issues
The House is expected to take up PDUFA legislation soon, and that has renewed the debate over the impact of the fees and the possibility of new requirements related to pharmacovigilance. PDUFA, which has to be reauthorized every five years, has been a hot topic of late. Critics maintain that PDUFA has given the drug industry …
... Read more...Latest Headlines
- October 5, 2007
- July 17, 2007
- July 5, 2007
- June 29, 2007
- November 6, 2006
- September 6, 2006
- September 5, 2006
- August 28, 2006
- August 8, 2006
- July 20, 2006
- July 17, 2006
- July 10, 2006
- July 2, 2006
- May 3, 2006
- April 23, 2006
- April 23, 2006
- March 15, 2006
- February 23, 2006
- November 27, 2005
- November 20, 2005
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
